Carmell (NASDAQ:CTCX) Stock Price Up 10.2% – Here’s Why

Carmell Co. (NASDAQ:CTCX)’s stock price rose 10.2% during mid-day trading on Friday . The stock traded as high as $3.16 and last traded at $3.09. Approximately 39,856 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 3,610,178 shares. The stock had previously closed at $2.80.

Carmell Price Performance

The firm’s 50 day simple moving average is $0.27 and its two-hundred day simple moving average is $0.30.

Institutional Investors Weigh In On Carmell

An institutional investor recently bought a new position in Carmell stock. Antara Capital LP acquired a new stake in shares of Carmell Co. (NASDAQ:CTCX) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 100,000 shares of the company’s stock, valued at approximately $28,000. Carmell accounts for about 0.0% of Antara Capital LP’s investment portfolio, making the stock its 10th largest position. Antara Capital LP owned 0.48% of Carmell at the end of the most recent reporting period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.